Catalyst Wire Dossier Catalyst Wire Dossier

EVOTAZ

atazanavir and cobicistat · E.R. Squibb & Sons, L.L.C.
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for EVOTAZ, covering 2015-01-29 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV [Phase 2, Phase 3]

See pricing